News
Discover how Skinopathy’s GetSkinHelp app is transforming skin cancer screening and fast-track treatment. Access ...
The Register on MSN54m
US medical org pays $50M+ to settle case after crims raided data and threatened to swat cancer patientsCash splashed on damages, infrastructure improvements, and fraud monitoring A Seattle cancer facility has agreed to fork out ...
Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...
A new AI test can detect which men with high-risk prostate cancer could benefit from a life-extending drug. The technology ...
When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...
GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...
Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...
qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...
Impact Statement: We present a novel solution for cervical abnormality screening using whole-slide images (WSIs). The screening task is crucial for public health as it helps identify cervical cancer ...
There’s a worrying trend in the cancer world with young adults getting cancer at higher rates, and scientists don’t know why.
The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results